Cargando…
The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
Coronavirus disease 2019 (COVID-19), caused by a novel betacoronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first described in a cluster of patients presenting with pneumonia symptoms in Wuhan, China, in December of 2019. Over the past few months, COVID-19 has developed...
Autores principales: | Tan, Weiyi, Aboulhosn, Jamil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102656/ https://www.ncbi.nlm.nih.gov/pubmed/32248966 http://dx.doi.org/10.1016/j.ijcard.2020.03.063 |
Ejemplares similares
-
Response to the letter, “The cardiovascular burden of congenital heart disease - not only in times of COVID-19”
por: Tan, Weiyi, et al.
Publicado: (2020) -
Coronavirus Disease 2019 (COVID‐19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease
por: Alsaied, Tarek, et al.
Publicado: (2020) -
Mechanical thrombectomy of COVID-19 DVT with congenital heart disease leading to phlegmasia cerulea dolens: a case report
por: Jamshidi, Neema, et al.
Publicado: (2021) -
Impact of Right-Sided-Catheter-Based Valve Implantation on Decision-Making in Congenital Heart Disease
por: Ghobrial, Joanna, et al.
Publicado: (2016) -
The cardiovascular burden of congenital heart disease - not only in times of COVID-19
por: Müller, Jan, et al.
Publicado: (2020)